Publications by authors named "David Reuss"

Claim this Profile
A
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.
Martin Sill, Daniel Schrimpf, Areeba Patel, Dominik Sturm, Natalie Jäger, David Reuss, Matthias Preusser

Cancer Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas.
Felix E Hinz, Dennis Friedel, Franziska M Ippen, Martin Sill, Andrey Korshunov, David E Reuss

Acta Neuropathol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM.
Elke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, Barbara C Jones, Sebastian Stark, David Reuss

Acta Neuropathol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expansion of the spectrum of tumors diagnosed as myxopapillary ependymomas.
Fuat Kaan Aras, Dennis Friedel, Felix Keller, Ferdinand Zettl, Rouzbeh Banan, David E Reuss

Acta Neuropathol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted and TERTp-wildtype: a grade 1 oligodendroglioma of young patients?
Filippo Nozzoli, Ramin Rahmanzade, Simone Schmid, Leonille Schweizer, Daniel Schrimpf, David E Reuss

Neuro Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing sarcoma diagnostics with expanded DNA methylation-based classification.
Natalie Jäger, David E Reuss, Martin Sill, Daniel Schrimpf, Abigail K Suwala

medRxiv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.
Martin Sill, Daniel Schrimpf, Areeba Patel, Dominik Sturm, Natalie Jäger, David Reuss, Matthias Preusser

medRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumors.
Florian Selt, Romain Sigaud, Andrey Korshunov, David Capper, David Reuss

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of CDKN2A/B hemizygous deletions in IDH-mutant glioma.
Franziska M Ippen, Thomas Hielscher, Dennis Friedel, Kirsten Göbel, David Reuss

Neuro Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread.
Felix Hinz, Dennis Friedel, Andrey Korshunov, Franziska M Ippen, Henri Bogumil, David E Reuss

Acta Neuropathol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design.
Ethan A Wetzel, Amin I Nohman, Annie L Hsieh, David Reuss, Andreas W Unterberg

J Neurooncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric spinal high-grade glioma in the pediatric precision oncology registry INFORM: Identification of potential therapeutic targets.
Elke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, Barbara C Jones, Sebastian Stark, David Reuss

Neurooncol Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial angioleiomyoma: a case series of seven patients and review of the literature.
Meltem Ivren, Asan Cherkezov, David Reuss, Daniel Haux, Christel Herold-Mende

J Neurooncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations.
Philipp Sievers, Franck Bielle, Kirsten Göbel, Daniel Schrimpf, Lucia Nichelli, David E Reuss

Acta Neuropathol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.
Kristyn Galbraith, Mekka Garcia, Siyu Wei, Anna Chen, Chanel Schroff, David Reuss

Neuro Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities.
Edgar Creus-Bachiller, Juana Fernández-Rodríguez, Miriam Magallón-Lorenz, Sara Ortega-Bertran, Susana Navas-Rutete, David Reuss

Mol Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype.
David E Reuss, Daniel Schrimpf, Asan Cherkezov, Abigail K Suwala, Tereza Lausová

Free Neuropathol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.
Ramin Rahmanzade, Elke Pfaff, Rouzbeh Banan, Philipp Sievers, Abigail K Suwala, David E Reuss

Acta Neuropathol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.
Martin Köbel, Rui Zhe Yang, Eun Young Kang, Zainab Al-Shamma, Linda S Cook, David E Reuss

Gynecol Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities.
Catena Kresbach, Matthias Dottermusch, Alicia Eckhardt, Inka Ristow, Petros Paplomatas, David Reuss

Neuro Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Nbs1 and p53 inactivation in neural progenitors triggers high-grade gliomas.
David E Reuss, Susanna M Downing, Cristel V Camacho, Yong-Dong Wang, Rosario M Piro

Neuropathol Appl Neurobiol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Henri Bogumil, Martin Sill, Daniel Schrimpf, Britta Ismer, Christina Blume, David E Reuss

Acta Neuropathol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Estimation in Non-Enhancing Glioma: Introducing a Clinical Score.
Philip Dao Trong, Samuel Kilian, Jessica Jesser, David Reuss, Fuat Kaan Aras

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature.
Philipp Sievers, Martin Sill, Daniel Schrimpf, Zied Abdullaev, Andrew M Donson, David E Reuss

NPJ Precis Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approach.
David E Reuss, Daniel Schrimpf, Damian Stichel, Azadeh Ebrahimi, Chris Dampier

Free Neuropathol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis